Federal tax code quietly penalizes state-legal cannabis businesses

What it does

This bill amends Section 280E of the Internal Revenue Code to clarify that marijuana businesses cannot deduct business expenses or claim tax credits, regardless of whether marijuana is legal under state law. Currently, Section 280E bars deductions for federally illegal drug trafficking; this bill extends that bar to marijuana specifically and adds language making clear the prohibition applies even in states where marijuana is legal.

Why we flagged it

The bill's operative mechanism is a tax deduction prohibition targeting a specific industry. While framed as maintaining existing law, it clarifies and potentially expands Section 280E to reach state-legal marijuana businesses, effectively imposing a federal tax penalty on an activity that is lawful under state law.

What the text implies

• State-legal cannabis businesses operating in compliance with state law will face federal tax treatment identical to illegal drug traffickers, creating a conflict between state and federal law that penalizes state-compliant operators.
• The amendment's reference to 'the law of any State in which such trade or business is conducted' may create ambiguity: does it mean the business is illegal in ANY state where it operates, or illegal in the state where it is conducted? This could affect multi-state operators.
• Cannabis businesses cannot deduct ordinary operating expenses (payroll, rent, utilities, inventory costs), forcing them to pay tax on gross revenue rather than net profit—a burden not imposed on other industries and effectively a hidden excise tax.
• The effective date applies to amounts paid after enactment, potentially retroactively affecting businesses that have already incurred expenses in the current tax year.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens in states where marijuana is legal lose access to a lawful business form that can deduct ordinary operating costs, effectively imposing a hidden federal tax penalty on state-legal cannabis businesses and their employees. This increases the effective tax burden on a lawful (under state law) industry, raising prices for consumers and reducing business viability in states that have legalized cannabis.

Who stands to gain

• U.S. Treasury (increased tax revenue from cannabis businesses)
• Illicit drug suppliers (reduced competition from state-legal cannabis operators facing higher effect

Named in the bill

Internal Revenue Service (IRS), Section 280E of Internal Revenue Code, Controlled Substances Act (CSA), Schedule I and II controlled substances, State cannabis regulatory bodies

Where it stands

2 cosponsors: 2 Republicans.

• Feb 6, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Feb 6, 2025 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

4 lobbying clients named this bill on 7 disclosure filings across 3 quarters, Dec 2025 to Jun 2026. Those filings disclosed $335,000 in lobbying spend. A filing names 2 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 72% of bills with at least one filing.

James Lankford, the sponsor, reported $368,500 in PAC receipts in the 2026 cycle.

• Sam Action, Inc. — $210,000 on 3 filings
• United States Cannabis Roundtable — $90,000 on 2 filings
• National Cannabis Industry Association — $25,000 on 1 filing
• National Cannabis Industry Association — $10,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.